{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:08:32Z","timestamp":1787501312608,"version":"build-2736575974"},"reference-count":14,"publisher":"Baishideng Publishing Group Inc.","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.4449","type":"journal-article","created":{"date-parts":[[2009,9,19]],"date-time":"2009-09-19T01:29:26Z","timestamp":1253323766000},"page":"4449","source":"Crossref","is-referenced-by-count":30,"title":["Stevens-Johnson syndrome complicating adalimumab therapy in Crohn\u2019s disease"],"prefix":"10.3748","volume":"15","author":[{"given":"Muna","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Craig","family":"Lawrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Ranganathan P. An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents. Curr Opin Mol Ther 2008;10:562-567."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Braun J, Deodhar A, Dijkmans B, Geusens P, Sieper J, Williamson P, Xu W, Visvanathan S, Baker D, Goldstein N. Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. Arthritis Rheum 2008;59:1270-1278.","DOI":"10.1002\/art.24001"},{"key":"ref3","unstructured":"Tzu J, Krulig E, Cardenas V, Kerdel FA. Biological agents in the treatment of psoriasis. G Ital Dermatol Venereol 2008;143:315-327."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat 2009;20:100-108.","DOI":"10.1080\/09546630802441234"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Rutgeerts P, Van Assche G, Vermeire S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 2004;126:1593-1610.","DOI":"10.1053\/j.gastro.2004.02.070"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-1035.","DOI":"10.1056\/NEJM199710093371502"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541-1549.","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007;132:52-65.","DOI":"10.1053\/j.gastro.2006.11.041"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 2006;130:323-333; quiz 591.","DOI":"10.1053\/j.gastro.2005.11.030"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Peyrin-Biroulet L, Deltenre P, de Suray N, Branche J, Sandborn WJ, Colombel JF. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 2008;6:644-653.","DOI":"10.1016\/j.cgh.2008.03.014"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lee HH, Song IH, Friedrich M, Gauliard A, Detert J, Röwert J, Audring H, Kary S, Burmester GR, Sterry W. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 2007;156:486-491.","DOI":"10.1111\/j.1365-2133.2007.07682.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Favalli EG, Desiati F, Atzeni F, Sarzi-Puttini P, Caporali R, Pallavicini FB, Gorla R, Filippini M, Marchesoni A. Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients. Autoimmun Rev 2009;8:266-273.","DOI":"10.1016\/j.autrev.2008.11.002"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-96.","DOI":"10.1001\/archderm.1993.01680220104023"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Fidder H, Schnitzler F, Ferrante M, Noman M, Katsanos K, Segaert S, Henckaerts L, Van Assche G, Vermeire S, Rutgeerts P. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut 2009;58:501-508.","DOI":"10.1136\/gut.2008.163642"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i35\/4449.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T14:37:42Z","timestamp":1558535862000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i35\/4449.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":14,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.4449","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}